Join us for a live, interactive webinar where expert faculty will take a deep dive into the clinical implications of EGFR exon 20 status in decision making, the role and timing of molecular profiling in diagnosis, and the efficacy and safety profiles of novel small molecular inhibitors in the treatment of advanced EGFR exon 20 insertion–mutant NSCLC. For your convenience, we are offering multiple days and times for this webinar. Please choose the date and time that is best for your learning needs. Register today!